ICRF-159 IN ADVANCED GASTRIC-CANCER - ABSENCE OF ACTIVITY

被引:1
作者
KRASNOW, S
BUNN, PA
IHDE, DC
MATTHEWS, MJ
COHEN, MH
EDDY, J
MINNA, JD
机构
[1] NCI,VET ADM MED ONCOL BRANCH,DIV CANC TREATMENT,BETHESDA,MD 20205
[2] VET ADM MED CTR,WASHINGTON,DC 20422
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1982年 / 5卷 / 06期
关键词
D O I
10.1097/00000421-198212000-00011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:635 / 639
页数:5
相关论文
共 21 条
[1]   EFFECT OF (+ OR -) 1,2-BIS(3,5-DIOXOPIPERAZIN-1-YL) PROPANE (ICRF 159) ON LIVER METASTASES FROM A HAMSTER LYMPHOMA [J].
ATHERTON, A .
EUROPEAN JOURNAL OF CANCER, 1975, 11 (06) :383-&
[2]  
BELLET RE, 1976, CANCER TREAT REP, V60, P1395
[3]  
Brugarolas A, 1978, Cancer Clin Trials, V1, P289
[4]  
BUNN PA, 1978, CANCER TREAT REP, V62, P1287
[5]  
CREAVEN PJ, 1974, CANCER CHEMOTH REP 1, V58, P393
[6]  
DOUGLASS HO, 1979, P AM ASSOC CANC RES, V20, P434
[7]  
GILBERT JM, 1979, RECENT RESULTS CANCE, V68, P317
[8]   COMBINATION OF RADIATION AND RAZOXANE (ICRF-159) INVIVO [J].
HELLMANN, K ;
GRIMSHAW, MB ;
HUTCHINSON, GE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (1-2) :109-113
[9]  
HUM GJ, 1976, P AM ASSOC CANC RES, V17, P155
[10]  
MACDONALD JS, 1979, CANCER, V44, P42, DOI 10.1002/1097-0142(197907)44:1<42::AID-CNCR2820440108>3.0.CO